In order to determine the compliance of Canadian physan average DBP of 95 mm Hg, 76% recommended therapy for patients with the same BP plus target organ icians with evidence-based hypertension guidelines, a self-administered questionnaire survey was distributed damage or other cardiovascular risk factors. Medication choices varied, although angiotensin-converting to a stratified random sample of 473 physicians in Central Alberta, Canada in December 1995. enzyme inhibitors were chosen by 46% for patients with uncomplicated essential hypertension and 67% for Excluding non-deliverable questionnaires, a response rate of 67% was obtained. Twenty-five per cent of patients with other cardiovascular risk factors, and betablockers were the most frequently chosen first-line respondents routinely used the fourth Korotkoff sound to define diastolic blood pressure (DBP). Investigations agents (56%) for the patient with target organ damage. There was considerable variability in the self-reported recommended for the initial workup of a patient with mild hypertension included serum creatinine (90%), practice patterns, and concordance was greater for those recommendations which were consistent across electrolytes (72%), glucose (50%), cholesterol (44%), electrocardiogram (65%), and urinalysis (76%). The nonthe currently available guidelines. Consistent with the principle underlying all of the current hypertension pharmacologic treatment advice routinely advocated for patients with mild hypertension included salt restriction guidelines, respondents were more aggressive in their treatment of hypertensive patients with other cardio-(87%), weight loss (100%), and regular aerobic exercise (92%). While 46% of respondents recommended antihyvascular risk factors or target organ damage. pertensive therapy for an otherwise healthy patient with
Introduction national guidelines). As published literature crosses
While large clinical trials provided unequivocal evinational boundaries and there is a great deal of disdence that the treatment of hypertension is benagreement between the guidelines on some issues, eficial, 1 epidemiological studies in the 1980s it would seem more appropriate in evaluating physrevealed that the rates of detection, treatment, and ician compliance to look only at those aspects of control of high blood pressure (BP) were subhypertension management for which all of the optimal.
2-5 In order to address this gap between prohypertension guidelines concur. ven efficacious management and clinical practice, a
The differences between the current hypertension number of national and international consensus guidelines have been extensively reported and panels have produced clinical practice guidelines debated, and include specified treatment thresholds, on the treatment of hypertension in the past decrecommended first-line therapy, and target BPs. On ade. [5] [6] [7] [8] [9] [10] [11] [12] However, previous surveys and practice the other hand, the areas in which the guidelines audits in hypertension [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] have revealed marked agree receive much less attention. 28 For instance, all inter-physician variability in the diagnosis, investistress the use of the Korotkoff phase V sound for gation, and treatment of patients with hypertension diastolic BP (DBP) estimation and the need for and reported significant discrepancies between repeated measurements over time before intervening physician practice patterns and guideline recin patients with elevated BP. All of the guidelines ommendations. While these studies have generated also agree on the importance of lifestyle modifia great deal of controversy, 27, 28 it should be recogcation in the management of mild hypertension, nized that these were largely done before the current with salt restriction, maintenance of ideal body evidence-based guidelines were widely dissemiweight, limitation of alcohol intake, and regular nated and tended to focus on physician compliance aerobic exercise universally recommended. Moreover, although there are some differences in the tests recommended by each set of guidelines, there is uni-esterol. Finally, and perhaps most importantly, there hypertension, and their approach to hypertensive smokers. For the purpose of this study, each survey is general agreement amongst the guidelines that the drug treatment threshold should be lower in patients also included three hypothetical clinical vignettes (in random order) designed to determine the responwith higher cardiovascular risk due to coexistent risk factors or target organ damage, although the dents' treatment thresholds for the initiation of pharmacologic therapy, their first-line antihypertenabsolute risk level warranting treatment remains an issue of debate.
sive choices, and the target BP they felt appropriate in each case. The three vignettes described patients In an effort to determine physician knowledge and acceptance of these consensus guidelines, a queswith different absolute cardiovascular risk profiles as follows: tionnaire survey was designed and distributed to clinicians caring for hypertensive patients. The
Case 1: A 45-year-old male with essential hypertenquestionnaire explored those issues where there was sion and no other cardiovascular risk factors reasonable concordance between the hypertension or evidence of target organ damage. guidelines, such as investigations and nonCase 2: A 45-year-old female with essential hyperpharmacologic treatment advice in mild hypertentension and multiple risk factors (smoking, sion. The survey also asked about areas of controobesity, hyperlipidaemia, family history of versy among the guidelines, such as treatment threpremature ischaemic heart disease), but no sholds, target BPs, and initial choice of medication.
target organ damage. As well, hypothetical scenarios were designed to Case 3: A 55-year-old male with essential hypertentest whether clinicians based their treatment sion and target organ damage manifest as decisions on the BP level alone or the absolute cararteriovenous nicking on fundoscopy, left diovascular risk.
ventricular hypertrophy, and myocardial infarction 3 years before. In addition to the description of overall opinions were stratified by specialty. A second mail-out and and survey responses, the responses of family physsubsequent telephone reminder was carried out in icians and internists were compared for certain key February 1996 for non-responders. The study was issues. The 2 test or Fisher's exact test were used closed in April 1996. Because we were interested in to test for differences in categorical variables and only those clinicians who dealt with hypertensive Student's t-test for differences in means. All tests patients, the major inclusion criterion for the survey were two-sided. As we planned to make multiple was that the respondent had cared for at least one comparisons, statistical significance was assumed hypertensive patient over the past year. Those clinat P Ͻ 0.01. icians who had not cared for a hypertensive patient were ineligible for the study and were asked to note
Materials and methods

Results
this on their survey and return it without filling it out. These blank surveys were not included in the Of the 473 questionnaires distributed, 54 were not final sample analysed. Surveys returned by postdeliverable as the physician had either retired graduate trainees and incomplete surveys were also and/or moved out of the region. Of the deliverable excluded from the final sample.
questionnaires, 281 (67%) were returned to the study coordinating centre. Sixty-eight surveys were excluded from further analysis: three were incomSurvey instrument plete, 48 were returned by physicians who reported that they had not cared for at least one hypertensive The study questionnaire was developed after review of previously published questionnaires on hypertenpatient in the past year, and 17 physicians reported that they were still in postgraduate training. The sion carried out in other practice settings. 14, 17, 20, [23] [24] [25] Pilot testing was done with 10 senior medical resifinal sample analysed consisted of 213 completed questionnaires (155 family physicians and 58 dents and subsequent face-to-face interviews were carried out to ensure the validity and clarity of the internists).
Although both groups of clinicians reported simiquestionnaire. Five residents repeated the questionnaire 3 weeks later to confirm its reliability. lar amounts of professional experience and saw similar numbers of hypertensive patients per month, In addition to demographic data, the survey included questions assessing the respondents' defithe internists were more likely to be male and to work in hospital settings in larger municipalities nition of DBP, the non-pharmacologic treatments and laboratory investigations they felt were always (Table 1) . A significant proportion of both groups (19% of indicated in newly diagnosed patients with mild Size of community: Population base Ͼ60 000 (%)** 55 79 *P Ͻ 0.0001; **P = 0.001.
internists and 27% of family physicians, P = NS) ordering of serum cholesterol and glucose, and an over-ordering of chest X-rays and liver function reported using the fourth Korotkoff Sound to determine DBP.
tests. The two physician cohorts provided similar There was considerable variability in the investigations recommended by family physicians and advice regarding lifestyle modifications to their hypertensive patients, and demonstrated a high rate internists for a hypothetical 45-year-old male newly diagnosed with hypertension ( Table 2) . Most of the of agreement with the published guidelines (Table 3) . Interestingly, although the overwhelming variability between the physician groups can be accounted for by the fact that family physicians majority reported that they always encouraged hypertensive smokers to stop smoking, only a mintended to order more 'biochemical panels' (a standard test panel which includes serum uric acid, calority referred these patients to smoking cessation programmes (14% of family physicians and 22% of cium, cholesterol, liver function tests, glucose, and creatinine) whereas internists tended to order the internists) or prescribed nicotine replacement therapy (35% and 22%). individual components of the biochemical panel separately. However, both groups demonstrated There were no significant differences between the two groups in their responses to each of the clinical marked variability compared to the recommended investigations in the consensus guidelines. In partivignettes with respect to treatment thresholds and target BPs, and the aggregate data are presented in cular, both groups exhibited a marked under- *P = 0.006; **P Ͻ 0.001.
Figures 1 and 2. As can be seen from Figure 1 , while quently chosen drugs for the uncomplicated patient and the patient with multiple cardiovascular risk there was some variability in the BP levels at which the respondents would prescribe antihypertensive factors, and beta-blockers were the most frequently chosen drug for the patient with a past history of drugs in each scenario, there was a gradation of response such that the hypothetical patients with myocardial infarction. The only statistically significant difference between family physicians and higher absolute cardiovascular risks (cases 2 and 3) were treated more aggressively than the patient with internists was the frequency of beta-blocker prescriptions for the patient with a history of myocaruncomplicated essential hypertension (case 1). Similarly, while most of the respondents advocated dial infarction. target BPs of Ͻ90 mm Hg with treatment, they tended to be more aggressive with their treatment Discussion recommendations in those patients with other cardiovascular risk factors or target organ damage In summary, while there are some areas of controversy, most of the physicians surveyed appear to (Figure 2) .
The initial medication choices of both physician approach the diagnosis, investigation, and treatment of hypertension in a similar fashion, and there is a cohorts were similar for each of the hypothetical cases (Table 4) . ACE inhibitors were the most frehigh degree of consistency for those issues in which concordance exists between the major guidelines. instance, the fact that 25% of the clinicians in our survey are using the fourth Korotkoff sound to deterFor instance, the lifestyle modifications recommended in all of the guidelines are virtually unimine DBP, which overestimates the true diastolic pressure by 5-10 mm Hg, 29 suggests that a signifiversally accepted and advocated by these physicians. Consistent with the principle underlying all cant proportion of patients labelled as 'hypertensive' may be in fact normotensive. In keeping with this of the guidelines that treatment should be started at lower BP levels in patients with higher absolute risk, postulation, a recent drug withdrawal study 30 found that approximately one-half of all treated hypertenthe respondents were more aggressive in their treatment of hypertensive patients with multiple risk facsive patients enrolled from a community setting remained normotensive 1 year after having their tors or pre-existing target organ damage than in those patients with uncomplicated hypertension.
antihypertensive agents stopped. Given the substantial ramifications for the individual 31 and the health Moreover, respondents were significantly less likely to recommend beta-blockers or thiazide diuretics in care system 32 of incorrectly labelling and treating normotensive subjects with antihypertensive medithe patient with hyperlipidaemia than in the patient with uncomplicated essential hypertension, and cations, increased emphasis in future guidelines and physician education efforts should be placed on rigwere much more likely to prescribe beta-blockers in the patient with a past history of myocardial infarcorously defining hypertension. The test-ordering behaviour demonstrated in the survey also requires tion. These practice patterns appear appropriate and consistent with the evidence-based recommenfurther comment. In brief, the tests recommended by expert panels 5,6,9-11 tended to be underutilized, dations of the current hypertension guidelines.
However, several other issues arise from the sursome tests with limited utility in hypertension were over-utilized, and other cardiovascular risk factors vey results which require further discussion. For (such as serum glucose and lipid levels) were inconof Hypertension (ISH) than those of the Canadian Hypertension Society (CHS). If his/her practice was sistently assessed. Similar test ordering variability and patterns of over/under-utilization have been compared only to the CHS recommendations, one may falsely conclude that he/she is non-compliant observed in physician surveys 19, 22, 24, 25 in other locales and provide an impetus for further research with hypertension guidelines in the several areas where the ISH and CHS guidelines differ. As such, into the factors that influence clinician test-ordering behaviour. Finally, although the vast majority of the it would seem more appropriate to determine compliance by looking at those aspects of hypertension respondents stated that they routinely advised their hypertensive patients who smoked to stop, only management which are consistently addressed in the existing guidelines. Using this method, we 32% had well-formulated plans to encourage smoking cessation.
would conclude that the practice patterns of the physicians who responded to this survey are conThe major deficiency of this study is that the data were obtained from a mailed survey with hypothetisistent with the current hypertension guidelines in several key areas. cal cases, and the self-reported practice patterns were unconfirmed by independent verification. While some authors 33, 34 have suggested that Acknowledgements reported management practice is closer to perceived ideal behaviour than actual behaviour, recent stud-
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